Bisphosphonate 연관 악골 괴사에 의해 발생한 부비동염 1예
A Case of Sinusitis due to Bisphosphonate Related Osteonecrosis of Jaw
0
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Bisphosphonates are used effectively for many medical conditions, such as multiple myeloma, Paget’s disease, osteoporosis, etc. However, recent case series and retrospective studies have established a relationship between necrotic bone lesions localized to the jaw and the use of chronic bisphosphonate therapy. This condition has been named bisphosphonate related osteonecrosis of the jaw (BRONJ). Although some cases with BRONJ affect the paranasal sinus, they have been rarely reported in otorhinolaryngology. Hence, we report a case of BRONJ with sinus involvement and a review of the relevant literature.
Abstract
Bisphosphonates are used effectively for many medical conditions, such as multiple myeloma, Paget’s disease, osteoporosis, etc. However, recent case series and retrospective studies have established a relationship between necrotic bone lesions localized to the jaw and the use of chronic bisphosphonate therapy. This condition has been named bisphosphonate related osteonecrosis of the jaw (BRONJ). Although some cases with BRONJ affect the paranasal sinus, they have been rarely reported in otorhinolaryngology. Hence, we report a case of BRONJ with sinus involvement and a review of the relevant literature.
참고문헌 (15)
- Epstein S, "Update of current therapeutic options for the treatment of postmenopausal osteoporosis", Clin Ther, 28(2), pp.151~173 (2006)
- Ruggiero SL, "Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases", J Oral Maxillofac Surg, 62(5), pp.527~534 (2004)
- Brooks JK, "Osteonecrosis of the jaws associated with use of risedronate: report of 2 new cases", Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 103(6), pp.780~786 (2007)
- Wynn RL, "Oral bisphosphonates and osteonecrosis of the jaw", Gen Dent, 55(1), pp.8~10 (2007)
- Marx RE, "Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic", J Oral Maxillofac Surg, 61(9), pp.1115~1117 (2003)
- Migliorati CA, "Bisphosphanates and oral cavity avascular bone necrosis", J Clin Oncol, 21(22), pp.4253~4254 (2003)
- Khosla S, "Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research", J Bone Miner Res, 22(10), pp.1479~1491 (2007)
- 박정철, "Bisphosphonates induced osteonecrosis of the jaw의 기전, 예방, 위험 평가 및 치료 방법", Journal of Periodontal & Implant Science, 39(1), pp.1~8 (2009), 대한치주과학회
- 오주영, "Bisphosphonate-related osteonecrosis of the jaw의 병리조직학적 소견 및 방사선학적 특징에 대한 임상적 고찰", 대한구강악안면외과학회지, 34(5), pp.550~554 (2008), 대한구강악안면외과학회
- 대한내분비학회, "비스포스포네이트와 관련한 악골(턱뼈) 괴사", Endocrinology and Metabolism, 24(4), pp.227~230 (2009), 대한내분비학회
- Dixon RB, "Bone turnover in elderly canine mandible and tibia", J Dent Res, 76, pp.336~ (1997)
- Alakangas A, "Alendronate disturbs vesicular trafficking in osteoclasts", Calcif Tissue Int, 70(1), pp.40~47 (2002)
- Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons., "American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws", J Oral Maxillofac Surg, 65(3), pp.369~376 (2007)
- Etminan M, "Use of oral bisphosphonates and the risk of aseptic osteonecrosis: a nested case-control study", J Rheumatol, 35(4), pp.691~695 (2008)
- Black DM, "Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial", JAMA, 296(24), pp.2927~2938 (2006)